# Velicept Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/velicept-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Wayne, US
- Website: www.velicept.com
- Total disclosed funding: $36M
- Latest round: Series B (Oct 16, 2018)
- Investors on record: 6

## About

Founded in 2015 and based in Pennsylvania, US, Velicept Therapeutics, Inc. is a clinical-stage pharmaceutical company that develops Solabegron, a therapeutic drug for treating urological and gastrointestinal disorders such as overactive bladder (OAB) and irritable bowel syndrome (IBS).

## Funding rounds

- Series B, Oct 16, 2018, $15M — Longitude Capital, Fountain Healthcare Partners, Becker Ventures, CDK Ventures, Samsara BioCapital
- Series B, Dec 1, 2015, $21M — Longitude Capital, CAM Capital

## Investors

- Longitude Capital (https://capitalatlas.ai/funds/longitude-capital) — Series B
- CAM Capital — Series B
- Fountain Healthcare Partners (https://capitalatlas.ai/funds/fountain-healthcare-partners) — Series B
- Becker Ventures (https://capitalatlas.ai/funds/becker-ventures) — Series B
- CDK Ventures — Series B
- Samsara BioCapital (https://capitalatlas.ai/funds/samsara-biocapital) — Series B